Millipore Sigma Vibrant Logo
Attention: We have moved. Merck Millipore products are no longer available for purchase on MerckMillipore.com.Learn More

MAB2630 Anti-KRIT-1 Antibody, clone 15

Anti-KRIT-1 Antibody, clone 15 detects level of KRIT-1 & has been published & validated for use in IC, IP & WB.

Anti-KRIT-1 Antibody, clone 15 MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.
Research Category: Cell Structure Research Sub-Category: Adhesion (CAMs) Gene Symbol: KRIT1, CAM, CCM1 UniProt Number: O00522
View Products on Sigmaaldrich.com
MAB2630
100 µg  
Purchase on Sigma-Aldrich

Special Offers

Overview

Replacement Information

Special Offers

100% Performance Guaranteed

Key Spec Table

Species ReactivityKey ApplicationsHostFormatAntibody Type
HICC, IPMPurifiedMonoclonal Antibody
Description
Catalogue NumberMAB2630
DescriptionAnti-KRIT-1 Antibody, clone 15
Alternate Names
  • Cerebral cavernous malformations 1 protein
  • Krev interaction trapped 1
Background InformationCerebral cavernous malformation (CCM), a disease associated with defective endothelial junctions, results from autosomal dominant CCM1 mutations that cause a loss of KRIT-1 protein function. CCM1 has been identified as the KRIT-1 gene. The protein product, KRIT-1, also known as Krev interaction trapped protein 1, is a microtubule-associated protein involved in endothelial cell-cell and cell-extracellular matrix interactions. KRIT-1 binds to Rap1 that maintains the integrity of endothelial junctions. It is reported that KRIT-1 colocalizes and is physically associated with junctional proteins via its band 4.1/ezrin/radixin/moesin (FERM) domain, (Glading, 2007).
References
Product Information
FormatPurified
Control
  • HeLa, A431, and HUVECs.
PresentationPurified mouse monoclonal IgG2bκ in buffer containing 0.1 M Tris-Glycine (pH 7.4, 150 mM NaCl) with 0.05% sodium azide.
Quality LevelMQ100
Applications
ApplicationAnti-KRIT-1 Antibody, clone 15 detects level of KRIT-1 & has been published & validated for use in IC, IP & WB.
Key Applications
  • Immunocytochemistry
  • Immunoprecipitation
Biological Information
ImmunogenGST-tagged recombinant protein corresponding to human KRIT-1 at and around the FERM domain.
EpitopeFERM domain
Clone15B2
ConcentrationPlease refer to the Certificate of Analysis for the lot-specific concentration.
HostMouse
SpecificityThe antibody recognizes KRIT-1.
IsotypeIgG2bκ
Species Reactivity
  • Human
Antibody TypeMonoclonal Antibody
Entrez Gene Number
Entrez Gene SummaryThis gene encodes a protein containing four ankyrin repeats, a band 4.1/ezrin/radixin/moesin (FERM) domain, and multiple NPXY sequences. The encoded protein is localized in the nucleus and cytoplasm. It binds to integrin cytoplasmic domain-associated protein-1 alpha (ICAP1alpha), and plays a critical role in beta1-integrin-mediated cell proliferation. It associates with junction proteins and RAS-related protein 1A (Rap1A), which requires the encoded protein for maintaining the integrity of endothelial junctions. It is also a microtubule-associated protein and may play a role in microtubule targeting. Mutations in this gene result in cerebral cavernous malformations. Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq].
Gene Symbol
  • KRIT1
  • CAM
  • CCM1
Purification MethodProtein G Purified
UniProt Number
UniProt SummarySUBUNIT STRUCTURE: Interacts with RAP1A.

SUBCELLULAR LOCATION: Membrane; Peripheral membrane protein Probable.

TISSUE SPECIFICITY: Low levels in brain. Very weak expression found in heart and muscle.

INVOLVEMENT IN DISEASE: Defects in KRIT1 are the cause of cerebral cavernous malformations type 1 (CCM1) [MIM:116860]. Cerebral cavernous malformations (CCMs) are congenital vascular anomalies of the central nervous system that can result in hemorrhagic stroke, seizures, recurrent headaches, and focal neurologic deficits. CCMs have an incidence of 0.1%-0.5% in the general population and usually present clinically during the 3rd to 5th decade of life. The lesions are characterized by grossly enlarged blood vessels consisting of a single layer of endothelium and without any intervening neural tissue, ranging in diameter from a few millimeters to several centimeters.

SEQUENCE SIMILARITIES: Contains 4 ANK repeats.

Contains 1 FERM domain.
Molecular Weight~ 84 kDa
Physicochemical Information
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Quality AssuranceImmunocytochemistry Analysis: 1:500 dilution of this antibody detected KRIT-1 in HeLa, A431, and HUVECs.
Usage Statement
  • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Storage and Shipping Information
Storage ConditionsStable for 1 year at 2-8°C from date of receipt.
Packaging Information
Material Size100 µg
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
Catalogue Number GTIN
MAB2630 04053252662249

Documentation

Anti-KRIT-1 Antibody, clone 15 SDS

Title

Safety Data Sheet (SDS) 

Anti-KRIT-1 Antibody, clone 15 Certificates of Analysis

TitleLot Number
Anti-KRIT-1, clone 15B2 - 2028603 2028603
Anti-KRIT-1, clone 15B2 - 2196100 2196100
Anti-KRIT-1, clone 15B2 - 3956120 3956120
Anti-KRIT-1, clone 15B2 - NG1868834 NG1868834
Anti-KRIT-1, clone 15B2 - NG1941998 NG1941998
Anti-KRIT-1, clone 15B2 - NRG1693919 NRG1693919
Anti-KRIT-1, clone 15B2 -2554914 2554914
Anti-KRIT-1, clone 15B2 -2568132 2568132
Anti-KRIT-1, clone 15B2 -2683926 2683926
Anti-KRIT-1, clone 15B2 -2891866 2891866
Show more